612
A.S. Voisin-Chiret et al. / Tetrahedron 65 (2009) 607–612
d
¼8.29 (d, 3JHH¼5.2, 1H), 8.27 (d, 3JHH¼5.4, 1H), 7.89 (s, 1H), 7.77 (s,
References and notes
3
3
1H), 7.67 (d, JHH¼5.2, 1H), 7.64 (d, JHH¼5.4, 1H); m/z: 314; HRMS
ꢀ
(EI) calcd for C10H6Br2N2 (Mþ ) 311.8897, found 311.8903.
1. (a) Constable, E. C. Angew. Chem., Int. Ed. 2007, 46, 2748–2749; (b) Constable,
E. C. Prog. Inorg. Chem. 1994, 42, 67–138; (c) Constable, E. C. Adv. Inorg. Chem.
1986, 30, 69–121.
2. Fang, Y.-Q.; Polson, M. I. J.; Hanan, G. S. Inorg. Chem. 2003, 42, 5–7.
3. Kozhevnikov, V. N.; Kozhevnikov, D. N.; Rusinov, V. L.; Chupakhin, O. N.; Koenig,
B. Synthesis 2003, 15, 2400–2404.
4. Hofmeier, H.; Gohy, J.-F.; Schubert, U. S. Abstracts of Papers, 225th National
Meeting of the American Chemical Society, New Orleans, LA, March 23–27,
2003; American Chemical Society: Washington, DC, 2003; 69DSA4.
5. Mirzadeh, S.; Packard, A. B. Abstracts of Papers, 210th National Meeting of the
American Chemical Society, Chicago, IL, Aug 20–24, 1995; American Chemical
Society: Washington, DC, 1995; 61XGAC.
4.2.11. 4,60-Dibromo-2,30-bipyridine 22
Beige solid (20%). Mp 142 ꢂC. IR (KBr): 3044, 1562, 1444, 1383,
1089, 1011, 823, 797 cmꢁ1. 1H NMR (400 MHz, DMSO-d6):
d
¼9.09 (s,
1H), 8.58 (d, 3JHH¼5.1, 1H), 8.43 (d, 1H, 3JHH¼8.4), 8.40 (s, 1H), 7.79
3
3
(d, JHH¼8.4, 1H), 7.73 (d, JHH¼5.1, 1H); m/z: 314; HRMS (EI) calcd
ꢀ
for C10H6Br2N2 (Mþ ) 311.8897, found 311.8891.
4.2.12. 600,6-Dichloro-3,20:40,300-terpyridine 23
6. Lowe, G.; Droz, A. S.; Vilaivan, T.; Weaver, G. W.; Tweedale, L.; Pratt, J. M.; Rock,
P.; Yardley, V.; Croft, S. L. J. Med. Chem. 1999, 42, 999–1006.
Halopyridylboronic acid (2.5 equiv), 1 equiv of halopyridine, 10
% tetrakis(triphenylphosphine) palladium(0), and 5 equiv
7. Ross, S. A.; Carr, C. A.; Briet, J. W.; Lowe, G. Anti Cancer Drug Des. 2000,15, 431–439.
8. (a) Zhao, L. X.; Kim, T. S.; Ahn, S. H.; Kim, T. H.; Kim, E. K.; Cho, W. J.; Choi, H.;
Lee, C. S.; Kim, J. A.; Jeong, T. C.; Chang, C. J.; Lee, E. S. Bioorg. Med. Chem. Lett.
2001, 11, 2659–2662; (b) Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong,
B. S.; Jeong, T. C.; Lee, C. S.; Lee, E. S. Bioorg. Med. Chem. 2007, 15, 4351–4359.
9. Fukuuchi, T.; Doh-ura, K.; Yoshihara, S.; Ohta, S. Bioorg. Med. Chem. Lett. 2006,
16, 5982–5987.
10. Shi, A.; Pokhrel, M. R.; Niederweis, M.; Bossmann, S. H. Abstracts of Papers, 40th
Midwest Regional Meeting of the American Chemical Society, Joplin, MO, Oct
26–29, 2005; American Chemical Society: Washington, DC, 2005; 69HOLN.
11. Kem, W. R.; Scott, K. N.; Duncan, J. H. Experientia 1976, 32, 684–686.
12. Kem, W. R. Hydrobiologia 1988, 156, 145–151.
mol
aqueous Na2CO3 are used. White solid (77%). Mp 226 ꢂC. IR (KBr):
3057, 1601, 1569, 1452, 1345, 1110, 1020, 1010, 831 cmꢁ1 1H NMR
.
4
3
(400 MHz, CDCl3):
d
¼8.96 (d, JHH¼2.5, 1H), 8.75 (d, JHH¼5.1, 1H),
4
3 4
8.65 (d, JHH¼2.6, 1H), 8.30 (dd, JHH¼8.4, JHH¼2.5, 1H), 7.88 (dd,
3JHH¼8.2, JHH¼2.6, 1H), 58 (s, 1H), 7.80 (s, 1H), 7.45–7.34 (m, 3H);
4
13C NMR (100 MHz, CDCl3):
d
¼154.7, 150.9, 150.5, 148.1, 147.9, 145.3,
ꢀ
137.2, 137.1; HRMS (EI): m/z: 301 calcd for C15H9Cl2N3 (Mþ
)
301.0173, found 301.0162.
13. Kem, W. R.; Soti, F. Hydrobiologia 2001, 456, 221–231.
14. (a) Pictet, A.; Rotschy, A. Chem. Ber. 1901, 34, 696–708; (b) Pictet, A. Arch. Pharm.
(Weinheim, Ger.) 1906, 244, 375–389.
4.2.13. 5,60-Dibromo-2,30-bipyridine 26
Yellow solid (77%). Mp 194 ꢂC. IR (KBr): 3010, 1575, 1461, 1376,
15. Yamamoto, Y.; Azuma, Y.; Mitoh, H. Synthesis 1986, 7, 564–565.
16. Yamamoto, Y.; Tanaka, T.; Yagi, M.; Inamoto, M. Heterocycles 1996, 42, 189–194.
17. (a) Cruskie, M. P., Jr.; Zoltewicz, J. A.; Abboud, K. A. J. Org. Chem. 1995, 60, 7491–
7495; (b) Zoltewicz, J. A.; Cruskie, M. P., Jr. Tetrahedron 1995, 51, 11401–11410.
18. Bouillon, A.; Voisin, A. S.; Robic, A.; Lancelot, J. C.; Collot, V.; Rault, S. J. Org.
Chem. 2003, 68, 10178–10180.
1090, 1005, 823 cmꢁ1
.
1H NMR (400 MHz, CDCl3):
d
¼8.92 (d,
4
3
4
4JHH¼2.0, 1H), 8.76 (d, JHH¼2.0, 1H), 8.18 (dd, JHH¼8.8, JHH¼2.0,
1H), 7.93 (dd, 3JHH¼8.8, 4JHH¼2.0, 1H), 7.64 (d, 3JHH¼8.8, 1H), 7.60 (d,
3JHH¼8.8, 1H); 13C NMR (100 MHz, CDCl3):
¼152.1, 151.3, 148.3,
d
19. Parry, P. R.; Wang, C.; Batsanov, A. S.; Bryce, M. R.; Tarbit, B. J. Org. Chem. 2002,
67, 7541–7543.
143.0, 139.7, 136.6, 133.1, 128.2, 121.3, 120.6; HRMS (EI): m/z calcd
ꢀ
for C10H6Br2N2 (Mþ ) 311.8897, found 311.8892.
20. Lehmann, U.; Henze, O.; Schlu¨ ter, A. D. Chem.dEur. J. 1999, 5, 854–859.
21. For leading references, see: (a) Miyaura, N. In Metal-Catalysed Cross-Coupling
Reactions; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: New York, NY, 2004;
Chapter 2; (b) Suzuki, A. In Hand-book of Organopalladium Chemistry for Organic
Synthesis; Negishi, E. I., Ed.; Wiley Intersciences: New York, NY, 2002; Chapter
III.2.2.
22. Schroeter, S.; Stock, C.; Bach, T. Tetrahedron 2005, 61, 2245–2267.
23. (a) Handy, S. T.; Zhang, Y. Chem. Commun. 2006, 299–301; (b) Handy, S. T.;
Sabatini, J. J. Org. Lett. 2006, 8, 1537–1539.
4.2.14. 3,20:50,200:500,3%-Quaterpyridine 27
Pyridylboronic acid (2.5 equiv), 1 equiv of halopyridine, 10 mol
% tetrakis(triphenylphosphine) palladium(0), and 5 equiv aqueous
Na2CO3 are used. Beige solid (41%). Mp 198 ꢂC. IR (KBr): 3420,
3036, 1584, 1465, 1360, 1013, 804, 710 cmꢁ1
.
1H NMR
24. Fairlamb, I. J. S. Chem. Soc. Rev. 2007, 36, 1036–1045.
4
5
(400 MHz, CDCl3):
d
¼9.40 (dd, JHH¼2.3, JHH¼0.8, 1H), 9.31 (dd,
25. (a) Bouillon, A.; Lancelot, J. C.; Collot, V.; Bovy, P. R.; Rault, S. Tetrahedron 2002,
58, 2885–2890; (b) Bouillon, A.; Lancelot, J. C.; Collot, V.; Bovy, P. R.; Rault, S.
Tetrahedron 2002, 58, 3323–3328; (c) Bouillon, A.; Lancelot, J. C.; Collot, V.;
Bovy, P. R.; Rault, S. Tetrahedron 2002, 58, 4369–4373; (d) Bouillon, A.; Lancelot,
J. C.; Collot, V.; Bovy, P. R.; Rault, S. Tetrahedron 2003, 59, 10043–10049.
26. Unpublished results.
27. Handy, S. T.; Wilson, T.; Muth, A. J. Org. Chem. 2007, 72, 8496–8500.
28. These yields are particularly low. We did not observe debromination of the
boronic acid but we noticed a protodeboronation reaction in such a way that
we recovered small amounts of starting materials. Moreover, in cross-coupling
reactions, we often observed a polymerization reaction leading to by-products,
which are not isolated.
4JHH¼2.3, 5JHH¼0.8, 1H), 9.01 (dd, 4JHH¼2.3, 5JHH¼0.8, 1H), 8.95 (dd,
4JHH¼2.3, JHH¼0.8, 1H), 8.72 (dd, JHH¼1.8, JHH¼4.8, 1H), 8.71
5
4
3
(dd, 4JHH¼1.8, 3JHH¼4.8, 1H), 8.54 (dd, 3JHH¼8.3, 4JHH¼2.3, 1H), 8.44
3
4
4
3
(ddd, JHH¼7.9, JHH¼2.3, JHH¼1.8, 1H), 8.06 (dd, JHH¼8.3,
4JHH¼2.3, 1H), 7.98 (ddd, JHH¼7.9, JHH¼2.3, JHH¼1.6, 1H), 7.97
3
4
4
(dd, 3JHH¼8.2, 5JHH¼0.8, 1H), 7.94 (dd, 3JHH¼8.3, 5JHH¼0.8, 1H), 7.48
3
3
5
3
(ddd, JHH¼7.9, JHH¼4.8, JHH¼0.8, 1H), 7.47 (ddd, JHH¼7.9,
3JHH¼4.8, JHH¼0.8, 1H); 13C NMR (100 MHz, CDCl3):
d¼155.5,
5
154.3, 150.6, 149.9, 148.9, 148.8, 148.7, 148.6, 135.8, 135.7, 134.8,
134.7, 134.6, 133.7, 133.4, 133.1, 124.3, 124.1, 120.9 (2C); HRMS (EI):
29. Preparation of other ter- and quater-pyridines will be described in a following
paper.
30. Unless otherwise specified.
ꢀ
m/z calcd for C20H14N4 (Mþ ) 310.1218, found 310.1208.